MTEM Molecular Templates Corp: רווח למניה אחת ב-12 החודשים האחרונים

Molecular Templates revenues are limited by licensing terms with pharma behemoths due to a lack of sales. The EPS YoY TTM percentage dynamics on GURU.Markets reflect the current trend, where the indicator is fixed at 68.90. Growth depends on the success of the ETB platform and new grants. Simultaneously, the company is reducing its environmental footprint by implementing renewable energy and wastewater treatment systems in its laboratories.
Molecular Templates Corp - פילוחים אנליטיים ומדדי מפתח (MTEM)

Molecular Templates creates unique protein toxins for cancer therapy, aiming for a future market monopoly. This indicator captures the annual dynamics of GAAP net earnings per share over 12 months. By analyzing the current annual EPS TTM growth rate, an investor can see the real pace of capital growth excluding one-time adjustments. This allows for a distinction between paper profits and sustainable financial success. The trend of this metric determines the margin of safety against potential price pullbacks.